The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity
Jeffrey Rubens(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Antoinette Price(Johns Hopkins University), Sabrina Wang(Johns Hopkins Medicine), Sariah J. Allen(St. Jude Children's Research Hospital), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Melanie Weingart(Sidney Kimmel Comprehensive Cancer Center), Brent A. Orr(St. Jude Children's Research Hospital)
Cited by 23
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711